Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

3.94
Delayed Data
As of 2:10pm ET
 +0.24 / +6.49%
Today’s Change
2.47
Today|||52-Week Range
13.91
+10.85%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close3.70
Today’s open3.64
Day’s range3.58 - 4.02
Volume245,010
Average volume (3 months)198,087
Market cap$40.8M
Dividend yield--
Data as of 2:10pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+11.54%
Earnings growth (this year)+17.39%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.69%
P/E ratioNM
Price/Sales8,984.64
Price/Book5.27

Competitors

 Today’s
change
Today’s
% change
APVOAptevo Therapeutics ...-0.08-4.06%
CLBSCaladrius Bioscience...-0.14-2.69%
VSTMVerastem Inc-0.04-3.20%
CSBRChampions Oncology I...+0.03+0.87%
Data as of 2:15pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$10.4K
Annual profit (last year)-$20.9M
Net profit margin-200,671.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Richard J. Daly
Chief Financial Officer
Jonathan B. Lloyd Jones
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs